Cellebrite DI Ltd.
CLBT
$15.52
-$0.48-3.00%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | 17.24% | 24.82% | 25.76% | 25.66% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 17.24% | 24.82% | 25.76% | 25.66% | |
| Cost of Revenue | 18.16% | 24.79% | 6.92% | 22.96% | |
| Gross Profit | 17.07% | 24.82% | 29.73% | 26.19% | |
| SG&A Expenses | 21.17% | 13.95% | 16.81% | 27.30% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 19.62% | 15.50% | 12.99% | 21.25% | |
| Operating Income | 4.85% | 170.11% | 6,699.26% | 55.04% | |
| Income Before Tax | 261.17% | 29.95% | -79.43% | -235.63% | |
| Income Tax Expenses | -72.72% | 95.22% | 3.92% | 13.74% | |
| Earnings from Continuing Operations | 231.56% | 26.39% | -75.77% | -306.94% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 231.56% | 26.39% | -75.77% | -306.94% | |
| EBIT | 4.85% | 170.11% | 6,699.26% | 55.04% | |
| EBITDA | 4.78% | 109.44% | 361.75% | 38.80% | |
| EPS Basic | 209.69% | 30.37% | -66.41% | -683.72% | |
| Normalized Basic EPS | 234.26% | 33.72% | -- | -228.90% | |
| EPS Diluted | 197.16% | 32.59% | -66.41% | -727.13% | |
| Normalized Diluted EPS | 226.70% | 33.72% | -- | -234.58% | |
| Average Basic Shares Outstanding | 19.96% | 5.75% | 5.63% | 5.13% | |
| Average Diluted Shares Outstanding | 27.21% | 5.75% | 5.63% | 0.86% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |